Clearance Summary
GENTAMICIN 120 UG, STREPTOMYCIN 30 UG SENSI-DISC SUSPECTIBILITY TESTS received FDA 510(k) clearance under submission number K943407, sponsored by Becton Dickinson Microbiology Systems. The device was reviewed via the Traditional premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 1994-10-27.
- Submission: K943407
- Applicant / Sponsor: Becton Dickinson Microbiology Systems
- Clearance pathway: Traditional
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.1620
- Decision date: 1994-10-27
Classification & Regulation
This clearance is catalogued under FDA product code JTN and 21 CFR 866.1620, within the Microbiology review panel as a Class II device.